SCHEMBL8540291

SCHEMBL8540291

CC1=C(C(N)=O)N=c2cc3c(c(C)c21)=Nc1ccccc1-3

nearest known ligand 0.33

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.33
IKBKB O14920 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CCNB2 O95067 1/20 0.31
CDK1 P06493 1/20 0.31
CCNB1 P14635 1/20 0.31
GSK3A P49840 1/20 0.31
GSK3B P49841 1/20 0.31
CDK5 Q00535 1/20 0.31
CDK5R1 Q15078 1/20 0.31
CCNB3 Q8WWL7 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.30
MAP2 P11137 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9057850 0.95 MYC (0.36) MYCIKBKB
SCHEMBL8910392 0.88 CCNB2 (0.32) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL8142537 0.88 MYC (0.34) MYCKMT2ACCNB2CDK1CCNB1
SCHEMBL8536552 0.86 GAA (0.32) ALDH1A1
SCHEMBL8149445 0.83 TERT (0.36) MEN1KMT2A
SCHEMBL8910714 0.82 ALDH1A1 (0.34) MEN1KMT2AALDH1A1HSD17B10
SCHEMBL8909578 0.82 HPGD (0.41) MEN1KMT2AALDH1A1
SCHEMBL8796475 0.82 MYC (0.35) MYCIKBKBMEN1KMT2ACCNB2
SCHEMBL8154324 0.80 LMNA (0.35)
SCHEMBL8146941 0.80 GRIN1 (0.39) HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770598-A ANTITUMOR AGENTS; REACTING WITH CARBONYL DIIMIDAZOLE AND AMIDOXIMES UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 1998-06-23 US disclosed
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed